PROM1 and neoplasm: Furthermore, immunofluorescence staining of ALDH1 and CD133 in xenografts verified that the fluorescence intensity of these stemness‐associated markers was decreased after administration of anlotinib in PC‐9‐derived LCSC tumour‐bearing mice.